drugs for PUD Flashcards
drugs that reduce intragastric activity
antacids
H2-R blocker
PPI
promote mucosal defense
sucralfate
prostaglandin analogs
colloidal bismuth compound
antacid drugs
sodium bicarbonate
calcium carbonate
Mg/Al hydroxide
antacid MOA
weak base
dec. intragastic act.; inc. prostaglandin
antacid dosage
single dose 156mEq 1h after meal to neutralize acid for 2hrs; 4x/d
drugs that react with antacid
fluroquinolone
itraconazole
iron
tetracycline
sodium bicarbonate AE
belching; exacerbate fluid retention;
calcium carbonate AE
belching; Milk-alkali syndrome; hyperCa; metab alkalosis
Mg/Al OH AE
Mg- osmotic diarrhea
AL- constipation
H2-R blocker drugs
(-tidine) cimetidine ranitidine famotidine nizatidine
H2-R blocker drugs pharmacodynamic
competitive inhibit parietal H2-R; dec. acid secretion
60-70% acid inhb
inhb nocturnal acid sec.
mod. inhb. on meal stim. acid sec.
H2-R blocker drugs pharmacokinetic
h- 1-4hrs 10hrs duration; BID hepa metab glomerular filtration renal tubular secretion
H2-R blocker drugs indication
GERD, PUD, dyspepsia, gastritis
H2-R blocker drugs AE
mental status change; C- gynecomastia, impotence, galactorrhea; cross placenta; bradycardia & hypotension; blood dyscrasia
H2-R blocker drugs with 100% bioavailability
Nizatidine
PPI drugs
(LORDEP) -prazole lansoprazole omeprazole rabeprazole dexlansoprazole esomeprazole pantoprazole
PPI pharmacokinetics
pKa 4-5 h-1.5hrs suppression for 24hrs complete acid suppression 2-3days taken 1hr before meal
hepatic ds reduces clearance of what PPIs?
esomeprazole, lansoprazole
first line mgmt for GERD
PPI
PPI indication
GERD, PUD, non-ulcer dyspepsia, mucosal bleeding, gastrinoma, NSAID-assoc. ulcer, H. pylori
PPI for GERD
OLE- omeprazole, lansoprazole, esomeprazole
PPI for NSAID-assoc. ulcer
LEP- pantoprazole, esomeprazole, lansoprazole
triple therapy for H. pylori
OCA- omeprazole, clarithromycin, amoxicillin
10-14 days